The Pristine Post-Market Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 142 participants.
Also called NCT05228132
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 142 participants
- Sponsor
- Registry
-
NCT05228132
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT05228132. Allocation not applicable; no masking; primary purpose treatment. Start 2022-05-16 (actual); primary completion 2022-09-21 (actual). Results posted on 2024-04-11.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Pristine Post-Market Study
- Condition
- Kidney Failure, Chronic
- Condition
- Hemodialysis Complication
- Condition
- Hemodialysis Catheter Infection
- Condition
- Hemodialysis Access Failure
- Condition
- Central Venous Catheter Related Bloodstream Infection
- Condition
- End Stage Renal Disease
- Intervention (Device)
- Pristine™ Long-Term Hemodialysis Catheter
- Lead sponsor
- C. R. Bard
Record details
- Record id
cardio:ct-nct05228132- Content hash
9267f12b92de6cd866deecd4a1e1ee618aa3aba90ad97b7b8411e053c94040fc